Lead Product(s) : Sulfadiazine
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : ZonMw | Universitaire Ziekenhuizen KU Leuven
Deal Size : Inapplicable
Deal Type : Inapplicable
Perioperative SDD to Prevent Infectious Complications After Esophagectomy
Details : Sulfadiazine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Esophageal Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 19, 2023
Lead Product(s) : Sulfadiazine
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : ZonMw | Universitaire Ziekenhuizen KU Leuven
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sulfadiazine
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Imperial College London | Sunnybrook Health Sciences Centre
Deal Size : Inapplicable
Deal Type : Inapplicable
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
Details : Sulfadiazine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Critical Illness.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 17, 2015
Lead Product(s) : Sulfadiazine
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Imperial College London | Sunnybrook Health Sciences Centre
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
